Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

TABLE 2: ¹H-MR spectroscopy findings in patients with late-onset G_M2G
Patient Thalamus White Matter Cerebellum
NAA Cr Cho NAA Cr Cho NAA Cr Cho
1 6.16 3.35 1.06 4.47 2.49 0.75 4.25 3.65 1.30
2 6.35 3.72 1.26 5.38 3.69 1.14 3.77 1.54 0.66
3 6.20 3.09 0.95 4.75 2.49 0.81 5.54 2.14 0.78
4 7.73 4.20 1.16 7.76 4.81 1.01 N/A N/A N/A
5 10.13 5.36 1.45 8.67 6.17 1.93 6.35 4.96 1.93
6 8.10 4.37 1.43 8.76 5.31 1.89 9.38 7.06 2.45
7 4.58 2.69 0.71 3.43 2.14 0.57 2.57 1.30 0.43
8 5.40 3.93 0.74 5.25 3.58 0.47 1.33 1.27 0.52
9 3.77 2.56 0.71 3.29 2.65 0.69 1.37 0.92 0.32
Patients 1–9 6.50 ± 1.9 3.69 ± 0.8 1.03 ± 0.3 5.75 ± 2.1 3.70 ± 1.4 1.05 ± 0.5 4.3 ± 2.7 2.9 ± 2.2 1.05 ± 0.8
Controls (n = 8) 11.0 ± 2.7 5.43 ± 1.2 1.43 ± 0.4 9.92 ± 2.7 5.20 ± 1.6 1.40 ± 0.4 11.1 ± 1.1 8.7 ± 1.3 2.4 ± 0.3
Concentrations of the 3 metabolites are in millimolars. Bold entries (for patients) are significantly different from the controls (P = .005).

Patient	Thalamus			White Matter			Cerebellum
Patient	NAA	Cr	Cho	NAA	Cr	Cho	NAA	Cr	Cho
1	6.16	3.35	1.06	4.47	2.49	0.75	4.25	3.65	1.30
2	6.35	3.72	1.26	5.38	3.69	1.14	3.77	1.54	0.66
3	6.20	3.09	0.95	4.75	2.49	0.81	5.54	2.14	0.78
4	7.73	4.20	1.16	7.76	4.81	1.01	N/A	N/A	N/A
5	10.13	5.36	1.45	8.67	6.17	1.93	6.35	4.96	1.93
6	8.10	4.37	1.43	8.76	5.31	1.89	9.38	7.06	2.45
7	4.58	2.69	0.71	3.43	2.14	0.57	2.57	1.30	0.43
8	5.40	3.93	0.74	5.25	3.58	0.47	1.33	1.27	0.52
9	3.77	2.56	0.71	3.29	2.65	0.69	1.37	0.92	0.32
Patients 1–9	6.50 ± 1.9	3.69 ± 0.8	1.03 ± 0.3	5.75 ± 2.1	3.70 ± 1.4	1.05 ± 0.5	4.3 ± 2.7	2.9 ± 2.2	1.05 ± 0.8
Controls (n = 8)	11.0 ± 2.7	5.43 ± 1.2	1.43 ± 0.4	9.92 ± 2.7	5.20 ± 1.6	1.40 ± 0.4	11.1 ± 1.1	8.7 ± 1.3	2.4 ± 0.3